AstraZeneca

In India, our focus is two-fold: bringing next‑generation therapies for patients faster and continuously innovating to expand access. Catch full conversation between Neetu Chandra Sharma and Praveen Rao Akkinepally reinforcing organisation's ambition and its building blocks.

Our rare disease business, Alexion Pharmaceuticals, Inc., recently announced an industry-first agreement with Carbon AMS to provide clean heat to its Dublin and Athlone sites in Ireland. A new facility in Duleek will add renewable capacity to Ireland’s national gas grid and produce 32 GWh of biomethane annually for Alexion. This milestone is an important step in our transition to 100% renewables and follows a series of innovative clean heat partnerships announced in the US, UK and China to decarbonise the production of medicines. Find out more about our approach to renewable energy: https://learn.az/60497WwTV #WhatScienceCanDo

🎗️Gastric cancer often goes unrecognised, making early detection vital to improving outcomes. When Mahati was first diagnosed, she was surprised – she had believed gastric cancer was almost non-existent. Her story shows how hard it can be to spot the signs and why raising awareness and encouraging early detection matter. Learn more about how early diagnosis and awareness can help transform care for people living with gastric cancer: https://learn.az/60487iWWm #GastricCancerAwarenessMonth

Infections caused by Clostridioides difficile, or C. diff, can be debilitating and potentially life-threatening, and the fear of recurrence can significantly hinder patients’ lives. Stories like Michael’s underscore the importance of advancing innovations to change lives. Learn more about how we’re rethinking C. diff prevention: https://learn.az/60427c43a #CdiffAwarenessMonth #CdiffInfectionAwareness

#BreakingNews 📢 Today we announced plans to invest $2 billion to expand our long-standing manufacturing footprint in Maryland. This investment is our fourth major US manufacturing announcement this year and part of the historic $50 billion commitment we made in July. Supporting 2,600 jobs and catalysing economic growth, this investment strengthens the resilience of the US medicines supply chain and accelerates access to transformative therapies for patients across America and around the world. #AZN #WhatScienceCanDo

In order to transform the future of cancer care, collaboration is essential. This week we hosted the inaugural Patient Advocacy Leaders Summit, convening 100 oncology patient advocacy leaders from across the globe. Their collective expertise and passion drove discussions on how to advance access, improve outcomes, and accelerate how we can work together to change the future for patients. Thank you to this inspiring group for your participation, feedback and collaboration.

Cell therapy has the potential to offer long-term remission, or even cure, across multiple diseases. Our approach goes beyond what’s possible today – pushing the boundaries of science by investing in state-of-the-art platforms, expanding global capabilities, and pioneering cell therapies at scale. By doing so, we’re working to eliminate the barriers that stand between patients and potentially life-changing treatments – and bring the future of medicine closer to becoming reality. Learn more here: https://learn.az/60487gh7Y #CellTherapy #Innovation #WhatScienceCanDo

Behind every diagnosis of chronic obstructive pulmonary disease (COPD) is a person with a story, fighting to breathe easier. It is a complex disease, affecting diverse populations with a range of causes. This World COPD Day, we’re encouraging greater COPD understanding to challenge outdated perceptions, support earlier diagnosis, improve access to care and transform patient outcomes worldwide. Join us and help make COPD a global policy priority: https://learn.az/60437d7Qd #WorldCOPDDay #SpeakUpForCOPD

Clostridioides difficile (C. diff) is a bacterium that can cause recurrent, potentially life-threatening infections, affecting hundreds of thousands of people each year. While November is #CdiffAwarenessMonth, our commitment to finding new ways to prevent and treat C. diff continues every day—so we can help people like Minnie. Hear more about Minnie’s decade-long journey with C. diff and why advancing care is so critical: https://learn.az/604775clz #CdiffInfectionAwareness

We have a bold ambition in oncology – to one day eliminate cancer as a cause of death. Our Oncology R&D strategy supports our ambition to transform outcomes for patients by attacking cancer from multiple angles, treating earlier and smarter, and leading with transformational technologies. Susan Galbraith, Executive Vice President, Oncology Haematology R&D, explains how we’re driving momentum and aiming to shape the future of cancer care: https://learn.az/60447dh62 #Innovation #WhatScienceCanDo